Pediococcus acidilactici

Cell therapyexperimental

Pediococcus acidilactici is a species of Gram-positive cocci that is often found in pairs or tetrads. P. acidilactici is a homofermentative bacterium that can grow in a wide range of pH, temperature, and osmotic pressure, therefore being able to colonize the digestive tract. It has emerged as a potential probiotic that has shown promising results in animal and human experiments. However, some of the results are limited. They are commonly found in fermented vegetables, fermented dairy products, and meat. — Wikipedia

Clinical trial activity

5 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Sep 3, 2018 (NCT04145856)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06968299N/AMay 20, 2025SunWay Biotech Co., LTD.
NCT04696458N/AApr 1, 2021Kaneka Corporation, Scripps
NCT04517422N/AAug 19, 2020AB Biotics, SA, Hospital Angeles del Pedregal, Hospital General Dr. Manuel Gea Gonzalez
NCT04164394N/AMay 13, 2019Hospital Juarez de Mexico
NCT04145856Phase 4Sep 3, 2018Hospital Juarez de Mexico
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hospital Juarez de MexicoAcademic/Hospital2222018
AB Biotics, SAFor profit1112020
Hospital Angeles del PedregalAcademic/Hospital1012020
Hospital General Dr. Manuel Gea GonzalezAcademic/Hospital1012020
Kaneka CorporationFor profit1012021
ScrippsAcademic/Hospital1112021
SunWay Biotech Co., LTD.For profit1112025
7 organizations
Page 1 / 1